Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Retained Earnings (2017 - 2025)

Akso Health (AHG) has disclosed Retained Earnings for 6 consecutive years, with -$63.9 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Retained Earnings fell 17.37% year-over-year to -$63.9 million, compared with a TTM value of -$63.9 million through Mar 2024, down 17.37%, and an annual FY2024 reading of -$63.9 million, down 17.37% over the prior year.
  • Retained Earnings was -$63.9 million for Q1 2024 at Akso Health, down from -$54.5 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$1.6 million in Q1 2022 and bottomed at -$63.9 million in Q1 2024.
  • Average Retained Earnings over 4 years is -$39.1 million, with a median of -$45.4 million recorded in 2021.
  • The sharpest move saw Retained Earnings soared 95.45% in 2022, then plummeted 3202.62% in 2023.
  • Year by year, Retained Earnings stood at -$36.3 million in 2021, then skyrocketed by 95.45% to -$1.6 million in 2022, then tumbled by 3202.62% to -$54.5 million in 2023, then decreased by 17.37% to -$63.9 million in 2024.
  • Business Quant data shows Retained Earnings for AHG at -$63.9 million in Q1 2024, -$54.5 million in Q1 2023, and -$1.6 million in Q1 2022.